AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter. The company now expects adjusted profit of between $11.13 and $11.33 per share for this year, compared with $10.97 to $11.17 estimated earlier. Analysts on average expect annual profit of $11.10 per share, according to LSEG data.
New sites in Barcelona and Dublin are set to open this quarter, the latter opening next month, and already has 95% pre-let occupancy. Both buildings will become the first of many to be based outside of the UK, strengthening the incspaces footprint in key European markets.
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Cocoa Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2024-2031 - (By Nature Coverage, Type Coverage, Form Coverage, End User, Geographic Coverage and By Company)" report has been added to ResearchAndMarkets.com's offering. The Global cocoa market is projected to reach US$15.5 billion by 2031, with a notable compound annual growth rate (CAGR) of 5.02% from 2024 to 2031. Factors such as increasing chocolate consumption, d
Symbole | Dernier cours | Variation | % variation |
---|---|---|---|
Symbole | Dernier cours | Variation | % variation |
---|---|---|---|
Symbole | Dernier cours | Variation | % variation |
---|---|---|---|
Symbole | Dernier cours | Variation | % variation |
---|---|---|---|
Symbole | Dernier cours | Variation | % variation |
---|---|---|---|
Symbole | Dernier cours | Variation | % variation |
---|---|---|---|
Symbole | Dernier cours | Variation | % variation |
---|---|---|---|
Symbole | Dernier cours | Variation | % variation |
---|---|---|---|